Koers India Globalization Capital, Inc. Nyse
Aandelen
US45408X1000
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 1,24 mln. 1,15 mln. | Omzet 2025 * | 1,4 mln. 1,3 mln. | Marktkapitalisatie | 34,02 mln. 31,59 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -12 mln. -11,14 mln. | Nettowinst (verlies) 2025 * | -10 mln. -9,29 mln. | EV/omzet 2024 * | 27,4 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 24,3 x |
K/w-verhouding 2024 * |
-2,34
x | K/w-verhouding 2025 * |
-3,22
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 79,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29-04-05 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 09-05-18 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29-04-05 |
Richard Prins
CHM | Chairman | 67 | 01-05-07 |
Director/Board Member | 79 | 18-01-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+1,17% | 42,65 mld. | |
+48,77% | 41,85 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |